Market Here’s why Aurobindo Pharma is Axis Securities’ pick of the week Updated : September 07, 2020 02:13 PM IST Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. Axis Securities expects the company’s earnings to grow at a CAGR of 13.5 percent over FY20-FY23E. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.